Literature DB >> 17043244

Isolation, characterization, and genetic complementation of a cellular mutant resistant to retroviral infection.

Sumit Agarwal1, Josephine Harada, Jeffrey Schreifels, Patrycja Lech, Bryan Nikolai, Tomoyuki Yamaguchi, Sumit K Chanda, Nikunj V Somia.   

Abstract

By using a genetic screen, we have isolated a mammalian cell line that is resistant to infection by retroviruses that are derived from the murine leukemia virus, human immunodeficiency virus type 1, and feline immunodeficiency virus. We demonstrate that the cell line is genetically recessive for the resistance, and hence it is lacking a factor enabling infection by retroviruses. The block to infection is early in the life cycle, at the poorly understood uncoating stage. We implicate the proteasome at uncoating by completely rescuing the resistant phenotype with the proteasomal inhibitor MG-132. We further report on the complementation cloning of a gene (MRI, modulator of retrovirus infection) that can also act to reverse the inhibition of infection in the mutant cell line. These data implicate a role for the proteasome during uncoating, and they suggest that MRI is a regulator of this activity. Finally, we reconcile our findings and other published data to suggest a model for the involvement of the proteasome in the early phase of the retroviral life cycle.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17043244      PMCID: PMC1636844          DOI: 10.1073/pnas.0602674103

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Genome-scale functional profiling of the mammalian AP-1 signaling pathway.

Authors:  Sumit K Chanda; Suhaila White; Anthony P Orth; Richard Reisdorph; Loren Miraglia; Russell S Thomas; Paul DeJesus; Daniel E Mason; Qihong Huang; Raquel Vega; De-Hua Yu; Christian G Nelson; Brendan M Smith; Robert Terry; Alicia S Linford; Yang Yu; Gung-wei Chirn; Chuanzheng Song; Mark A Labow; Dalia Cohen; Frederick J King; Eric C Peters; Peter G Schultz; Peter K Vogt; John B Hogenesch; Jeremy S Caldwell
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-26       Impact factor: 11.205

2.  Coreceptor usage of primary human immunodeficiency virus type 1 isolates varies according to biological phenotype.

Authors:  A Björndal; H Deng; M Jansson; J R Fiore; C Colognesi; A Karlsson; J Albert; G Scarlatti; D R Littman; E M Fenyö
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

3.  The chromosomes of a V79 Chinese hamster line and a mutant subline lacking HPRT activity.

Authors:  J Thacker
Journal:  Cytogenet Cell Genet       Date:  1981

4.  The pH independence of mammalian retrovirus infection.

Authors:  M O McClure; M A Sommerfelt; M Marsh; R A Weiss
Journal:  J Gen Virol       Date:  1990-04       Impact factor: 3.891

5.  Single amino acid changes in the murine leukemia virus capsid protein gene define the target of Fv1 resistance.

Authors:  C A Kozak; A Chakraborti
Journal:  Virology       Date:  1996-11-15       Impact factor: 3.616

6.  A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference.

Authors:  Douglas A Rubinson; Christopher P Dillon; Adam V Kwiatkowski; Claudia Sievers; Lili Yang; Johnny Kopinja; Dina L Rooney; Mingdi Zhang; Melanie M Ihrig; Michael T McManus; Frank B Gertler; Martin L Scott; Luk Van Parijs
Journal:  Nat Genet       Date:  2003-02-18       Impact factor: 38.330

7.  Retroviruses have differing requirements for proteasome function in the budding process.

Authors:  David E Ott; Lori V Coren; Raymond C Sowder; Julian Adams; Ulrich Schubert
Journal:  J Virol       Date:  2003-03       Impact factor: 5.103

8.  Restriction of multiple divergent retroviruses by Lv1 and Ref1.

Authors:  Theodora Hatziioannou; Simone Cowan; Stephen P Goff; Paul D Bieniasz; Greg J Towers
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

9.  The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys.

Authors:  Matthew Stremlau; Christopher M Owens; Michel J Perron; Michael Kiessling; Patrick Autissier; Joseph Sodroski
Journal:  Nature       Date:  2004-02-26       Impact factor: 49.962

10.  Positional cloning of the mouse retrovirus restriction gene Fv1.

Authors:  S Best; P Le Tissier; G Towers; J P Stoye
Journal:  Nature       Date:  1996-08-29       Impact factor: 49.962

View more
  13 in total

1.  A human short open reading frame (sORF)-encoded polypeptide that stimulates DNA end joining.

Authors:  Sarah A Slavoff; Jinho Heo; Bogdan A Budnik; Leslyn A Hanakahi; Alan Saghatelian
Journal:  J Biol Chem       Date:  2014-03-07       Impact factor: 5.157

2.  Recurrent mutations in multiple components of the cohesin complex in myeloid neoplasms.

Authors:  Ayana Kon; Lee-Yung Shih; Masashi Minamino; Masashi Sanada; Yuichi Shiraishi; Yasunobu Nagata; Kenichi Yoshida; Yusuke Okuno; Masashige Bando; Ryuichiro Nakato; Shumpei Ishikawa; Aiko Sato-Otsubo; Genta Nagae; Aiko Nishimoto; Claudia Haferlach; Daniel Nowak; Yusuke Sato; Tamara Alpermann; Masao Nagasaki; Teppei Shimamura; Hiroko Tanaka; Kenichi Chiba; Ryo Yamamoto; Tomoyuki Yamaguchi; Makoto Otsu; Naoshi Obara; Mamiko Sakata-Yanagimoto; Tsuyoshi Nakamaki; Ken Ishiyama; Florian Nolte; Wolf-Karsten Hofmann; Shuichi Miyawaki; Shigeru Chiba; Hiraku Mori; Hiromitsu Nakauchi; H Phillip Koeffler; Hiroyuki Aburatani; Torsten Haferlach; Katsuhiko Shirahige; Satoru Miyano; Seishi Ogawa
Journal:  Nat Genet       Date:  2013-08-18       Impact factor: 38.330

3.  BIRC2/cIAP1 Is a Negative Regulator of HIV-1 Transcription and Can Be Targeted by Smac Mimetics to Promote Reversal of Viral Latency.

Authors:  Lars Pache; Miriam S Dutra; Adam M Spivak; John M Marlett; Jeffrey P Murry; Young Hwang; Ana M Maestre; Lara Manganaro; Mitchell Vamos; Peter Teriete; Laura J Martins; Renate König; Viviana Simon; Alberto Bosque; Ana Fernandez-Sesma; Nicholas D P Cosford; Frederic D Bushman; John A T Young; Vicente Planelles; Sumit K Chanda
Journal:  Cell Host Microbe       Date:  2015-09-09       Impact factor: 21.023

4.  Ligand binding characteristics of the Ku80 von Willebrand domain.

Authors:  Kyungmin Kim; Jungki Min; Thomas W Kirby; Scott A Gabel; Lars C Pedersen; Robert E London
Journal:  DNA Repair (Amst)       Date:  2019-10-24

Review 5.  Discovery and characterization of smORF-encoded bioactive polypeptides.

Authors:  Alan Saghatelian; Juan Pablo Couso
Journal:  Nat Chem Biol       Date:  2015-12       Impact factor: 15.040

6.  MRI Is a DNA Damage Response Adaptor during Classical Non-homologous End Joining.

Authors:  Putzer J Hung; Britney Johnson; Bo-Ruei Chen; Andrea K Byrum; Andrea L Bredemeyer; William T Yewdell; Tanya E Johnson; Brian J Lee; Shruthi Deivasigamani; Issa Hindi; Parmeshwar Amatya; Michael L Gross; Tanya T Paull; David J Pisapia; Jayanta Chaudhuri; John J H Petrini; Nima Mosammaparast; Gaya K Amarasinghe; Shan Zha; Jessica K Tyler; Barry P Sleckman
Journal:  Mol Cell       Date:  2018-07-12       Impact factor: 17.970

7.  Characterization of resistance to rhabdovirus and retrovirus infection in a human myeloid cell line.

Authors:  Guney Boso; Nikunj V Somia
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

8.  A tractable method for simultaneous modifications to the head and tail of bacteriophage lambda and its application to enhancing phage-mediated gene delivery.

Authors:  Christine N Zanghi; Ramil Sapinoro; Birgit Bradel-Tretheway; Stephen Dewhurst
Journal:  Nucleic Acids Res       Date:  2007-03-28       Impact factor: 16.971

9.  Isolation and characterization of human cells resistant to retrovirus infection.

Authors:  Patrycja Lech; Nikunj V Somia
Journal:  Retrovirology       Date:  2007-07-03       Impact factor: 4.602

10.  The Ku-binding motif is a conserved module for recruitment and stimulation of non-homologous end-joining proteins.

Authors:  Gabrielle J Grundy; Stuart L Rulten; Raquel Arribas-Bosacoma; Kathryn Davidson; Zuzanna Kozik; Antony W Oliver; Laurence H Pearl; Keith W Caldecott
Journal:  Nat Commun       Date:  2016-04-11       Impact factor: 14.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.